Literature DB >> 31498767

ACE inhibitors and ARBs: Managing potassium and renal function.

Tasnim Momoniat1, Duha Ilyas1, Sunil Bhandari2.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are used primarily to treat hypertension and are also useful for conditions such as heart failure and chronic kidney disease, independent of their effect on blood pressure. This article reviews the indications for ACE inhibitors and ARBs and offers advice for managing their adverse effects, particularly declining renal function and hyperkalemia.
Copyright © 2019 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31498767     DOI: 10.3949/ccjm.86a.18024

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

Review 1.  Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.

Authors:  Lucía A Méndez-García; Galileo Escobedo; Alan Gerardo Minguer-Uribe; Rebeca Viurcos-Sanabria; José A Aguayo-Guerrero; José Damián Carrillo-Ruiz; Helena Solleiro-Villavicencio
Journal:  Front Cell Neurosci       Date:  2022-09-16       Impact factor: 6.147

2.  Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction.

Authors:  Chun-Yen Chiang; Sheng-Chung Huang; Michael Chen; Jhih-Yuan Shih; Chon-Seng Hong; Nan-Chun Wu; Chung-Han Ho; Chia Chun Wu; Zhih-Cherng Chen; Wei-Ting Chang
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.